The United States Food and Drug Administration (FDA) is facing challenges as they try to regulate the production and consumption of e-cigs in the states. As vapers grow in numbers and technology for these devices develops at an incredible pace, the FDA is struggling to keep up.
The FDA Could Seriously Stifle E-Cig Innovation
The FDA first attempted regulation in April 2014, proposing to outlaw e-cig sales to minors and impose health warning labels. According to the director of the FDA’s Center for Tobacco Products, Mitch Zeller, they also want to move towards approving all new vaping products before they’re released in the US market. If approved, many companies belive this could significantly decrease the technological advancements our industry is currently experiencing, as it will slow the process and delay product releases. It could also prevent or delay current cigarette smokers from switching to e-cigs.
On the contrary, some companies believe that government regulation would make consumers more comfortable with e-cigs, and could actually boost sales over time.
According the department’s website, they currently only have control over e-cigarettes that are marketed to consumers as therapeutic devices.
Why Can’t They Keep Up?
As demand grows, innovators in the e-cig industry are creating incredible new technologies for us to enjoy. The market is seeing fascinating new products, including Smokio, a device and app that link via Bluetooth and allow users to track their usage and view the benefits of switching from real cigarettes to e-cigarettes, such as money saved and improvements in health.
While these new apps and appliances are great for vapers, they make it a lot more difficult for governments to control. This is due to the fact that vaporizers vary greatly in shape, size, style, and function, among other features, as opposed to tobacco cigarettes, which are easy to monitor since they are essentially all the same.
The good news is that they’re not trying to eliminate the variety of e-liquid flavours and devices we currently enjoy, while you still can!
The FDA's moves could stifle innovation, but on the flip side, innovation could stifle the FDAs regulation. What do you think?